Cite
Inhibition of lung adenocarcinoma by combinations of sulfasalazine (SAS) and disulfiram-copper (DSF-Cu) in cell line models and mice.
MLA
Bagherpoor, Alireza Jian, et al. “Inhibition of Lung Adenocarcinoma by Combinations of Sulfasalazine (SAS) and Disulfiram-Copper (DSF-Cu) in Cell Line Models and Mice.” Carcinogenesis, vol. 44, no. 4, Apr. 2023, pp. 291–303. EBSCOhost, https://doi.org/10.1093/carcin/bgad020.
APA
Bagherpoor, A. J., Shameem, M., Luo, X., Seelig, D., & Kassie, F. (2023). Inhibition of lung adenocarcinoma by combinations of sulfasalazine (SAS) and disulfiram-copper (DSF-Cu) in cell line models and mice. Carcinogenesis, 44(4), 291–303. https://doi.org/10.1093/carcin/bgad020
Chicago
Bagherpoor, Alireza Jian, Mohammad Shameem, Xianghua Luo, Davis Seelig, and Fekadu Kassie. 2023. “Inhibition of Lung Adenocarcinoma by Combinations of Sulfasalazine (SAS) and Disulfiram-Copper (DSF-Cu) in Cell Line Models and Mice.” Carcinogenesis 44 (4): 291–303. doi:10.1093/carcin/bgad020.